Estrogen as a neuroprotectant against MPTP-Induced neurotoxicity in C57/B1 mice

Bazzett, 1994, Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding, Brain Res., 637, 163, 10.1016/0006-8993(94)91229-7 Bedard, 1977, Oestrogens and extrapyramidal system, Lancet, ii, 1367, 10.1016/S0140-6736(77)90429-9 Chen, 1995, Estrogen may protect females from parkinson's disease, Soc. Neurosci. Abstr., 21, 1252 Cleeter, 1992, Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement, J. Neurochem., 58, 786, 10.1111/j.1471-4159.1992.tb09789.x Del Zompo, 1993, Selective MPP+ uptake into synaptic dopamine vesicles possible involvement in MPTP neurotoxicity, Br. J. Pharmacol., 109, 411, 10.1111/j.1476-5381.1993.tb13584.x Diamond, 1990, An examination of male-female differences in the progression of Parkinson's disease, Neurology, 40, 763, 10.1212/WNL.40.5.763 Disshon, 1995, Estrogen as a neuroprotectant against MPTP-induced neurotoxicity: 2 Effects upon corpus striatal dopamine release, Int. Soc. Psychoneuroendocrinol. Abstr., 26, 29 Dluzen, 1996, Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system in male C57/B1 mice, Brain Res., 715, 113, 10.1016/0006-8993(95)01566-3 Dluzen, 1994, Modulatory effects of testosterone on 1-melhyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, J. Neurochem., 62, 94, 10.1046/j.1471-4159.1994.62010094.x Dluzen, 1996, Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release, J. Neurochem., 66, 658, 10.1046/j.1471-4159.1996.66020658.x Gerlach, 1991, MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease, Eur. J. Pharmacol., 208, 273, 10.1016/0922-4106(91)90073-Q Ghosh, 1993, Subcellular action of estradiol-17 beta in a freshwater prawn Macrobrachium rosenbergii, Gen. Comp. Endocrinol., 90, 274, 10.1006/gcen.1993.1082 Giovanni, 1994, Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration, J. Pharmacol. Exp. Ther., 200, 1000 Glazer, 1983, The relationship of circulating estradiol to tardive dyskinesia in men and postmenopausal women, Psychoneuroendocrinology, 8, 429, 10.1016/0306-4530(83)90022-7 Gomez-Mancilla, 1992, Effect of estrogen and progesterone on L-DOPA induced dyskinesia in MPTP-treated monkeys, Neurosci. Lett., 135, 129, 10.1016/0304-3940(92)90152-W Kitayama, 1993, Dopamine transporter mutants selectively enhance MPP + transport, Synapse, 15, 58, 10.1002/syn.890150107 McDermott, 1994, Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice, Exp. Neurol., 125, 306, 10.1006/exnr.1994.1034 Michel, 1987, Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists, Biochem. Pharmacol., 36, 3175, 10.1016/0006-2952(87)90629-0 Ramirez, 1983, Hormones and striatal dopamine activity: A novel neuroendocrine model, 97 Ruiz-Larrea, 1994, Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes, Steroids, 59, 383, 10.1016/0039-128X(94)90006-X Sziraki, 1994, Methamphetamine protects against MPTP neurotoxicity in C57B1 mice, Eur. J. Pharmacol., 251, 311, 10.1016/0014-2999(94)90416-2 Unzeta, 1994, Sex related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahyrdo-pyridine treatment may be related to differences in monoamine oxidase B, Neurosci. Lett., 176, 235, 10.1016/0304-3940(94)90090-6 van Hartesveldt, 1986, Effects of estrogen on the basal ganglia, Neurosci. Biobehav. Rev., 10, 1, 10.1016/0149-7634(86)90029-1